Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014


Hungary Life Sciences, Biotech & Healthcare Investment Conference

22 Jan 2014 - 22 Jan 2014 - Budapest, Hungary



Bookmark and Share


A not-to-be-missed event showcasing Hungary’s achievements as the most innovative pharmaceutical and healthcare hub in CEE and beyond. 

Get the first -hand information from the relevant industry professionals and assess the market potential.

The proposed conference is part of our Healthcare series of events dedicated to the Central European pharmaceutical and medical markets. Following the successful events concluded in Russia, Kazakhstan, Poland, Romania, Georgia, Azerbaijan and Ukraine, it is now Hungary’s turn to be showcased. Hungary’s life sciences and medical technology industry is well-developed and has been granted international recognition. Innovative SMEs are continuously growing in numbers and strength, while foreign med tech producers have indentified Hungary as an attractive investment destination, offering a highly productive workforce. Featuring one of the largest and most developed drug markets in CEE, Hungary ranks n°1 in the region for FDI in the pharmaceutical sector. Investors will find several fast-growing and renowned R&D institutions and the country has the highest number of biotech companies in the region and keeps attracting new ones. Registration process is open for delegates and we currently offer an early bird discount.


Further information
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!